ReviewFrontiers in oncology2022
Semaphorins as Potential Immune Therapeutic Targets for Cancer.
Jun Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Jun Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.